4:01pm ET
Investing
Nike, Visa Lead DJIA Down on Monday
November 28, 2016: Markets opened lower Monday after a long weekend of eating and shopping. There was no economic news of note, so this may just be a pause in an equity…
Companies
/Healthcare
Johnson & Johnson
$269.99
▼ $0.23 (−0.09%) today
Markets closed · 4:00pm ET
JNJ Coverage
Page 54
8:39am ET
Energy
Target, Walmart Lead Top 10 Adopters of Solar Energy
Solar energy adoption among large U.S. corporations has grown from a total installed base of 300 megawatts (MW) in 2012 to more than 1,000 MW this year. The total represents 16% of…
5:10pm ET
Investing
Major Changes in Warren Buffett & Berkshire Hathaway Stocks: American Airlines, Delta, Kinder Morgan, Wal-Mart, BNY Mellon and More
Outside of Warren Buffett being one of the richest men alive and being considered the greatest investor of modern times, there have been many key changes in the Buffett stocks over recent…
10:10am ET
Investing
Massive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan, AT&T, Kimberly-Clark, IBM, Johnson & Johnson and More
With the busiest earnings week behind us, it appears some of the restriction windows at major U.S. corporations are starting to open up a little.
7:45am ET
Health and Healthcare
Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma
Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even — for many biotech companies in the depression space.
10:35am ET
Investing
5 Dow Stocks Outperforming Analyst Expectations for 2016
Of the 30 Dow Jones Industrial Average stocks, only five of them have outperformed analyst expectations this year, though some have outperformed analyst expectations handily.
9:15am ET
Health and Healthcare
Johnson & Johnson Remains Flat Despite Earnings Beat
Johnson & Johnson released a better-than-expected third-quarter report before the markets opened on Tuesday.
Chris Lange 12:15pm ET
Health and Healthcare
What to Look for in Johnson & Johnson Earnings
Johnson & Johnson is expected to release its most recent earnings report before the markets open on Tuesday.
Chris Lange 10:20am ET
Investing
Top DJIA Earnings Reports in the Week Ahead
A third of the Dow Jones Industrial Average is reporting quarterly results this week, which has the potential to push the Dow back up to its highs.
10:50am ET
Investing
4 DJIA Stocks That Have Raised Dividends for Over 50 Years Straight
Here are four Dow stocks that have raised their dividends for 50 years or more, and that also appear to be able to keep raising their dividends in the years ahead.
11:50am ET
Investing
7 Giant Companies Raising Their Dividends for 25 Years or More
These corporate giants have stated or admitted on their own that they are in the 25-year dividend hike game.
10:50am ET
Health and Healthcare
New Crohn’s Disease Drug Approved by FDA
A unit of Johnson & Johnson has announced that the FDA has approved its Stelara for the treatment of moderately to severely active Crohn's disease.
Jon C. Ogg 10:25am ET
Health and Healthcare
Jefferies Issues Top Pharma and Biohealth Stocks to Buy
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
7:40am ET
Health and Healthcare
8 Major FDA Decisions and Trial Results to Watch for in September
24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.
4:01pm ET
Investing
Apple, J&J Weigh on DJIA Monday
August 22, 2016: Markets opened lower again Monday as investors remain cautious ahead of the Fed’s Jackson Hole conference beginning Thursday. Fed Chairwoman Janet Yellen is scheduled to speak on Friday and…